Cochrane · systematic review · CD010481
Amphotericin B deoxycholate versus liposomal amphotericin B: effects on kidney function
Botero Aguirre, JP, Restrepo Hamid, AM · Cochrane Database of Systematic Reviews · 2015 · Cochrane Library
Kidney and TransplantAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
1
current version
GRADE rated
1
No studies
0
Included studies
NR
No studies 0 · 0%Ungraded 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 1 · 100%High 0 · 0%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
Questions and results
Amphotericin B deoxycholate versus liposomal amphotericin B: effects on kidney function
Population: patients in treatment with amphotericin B
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Increase in SCr level: ≥ two‐fold from baseline level SCr level (mg/dL) Amphotericin B deoxycholate vs liposomal amphotericin B: effects on kidney function | RR 0.49 [0.4, 0.59] | 10 studies · 2172 participants | Moderate |